Seeing Is Believing
TVTX is currently covered by 12 analysts with an average price target of $43.16. This is a potential upside of $15.1 (53.81%) from yesterday's end of day stock price of $28.06.
Travere Therapeutics's activity chart (see below) currently has 191 price targets and 142 ratings on display. The stock rating distribution of TVTX is 92.59% BUY and 7.41% HOLD.
Analysts average stock forecasts to be materialized ratio is 41.73% with an average time for these price targets to be met of 176 days.
Highest price target for TVTX is $47, Lowest price target is $20, average price target is $35.5.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 18-Sep-2025.
Currently out of the existing stock ratings of TVTX, 25 are a BUY (92.59%), 2 are a HOLD (7.41%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$47
$19.68 (72.04%)
$47
1 months 6 days ago
(18-Sep-2025)
0/4 (0%)
$22.15 (89.13%)
Hold
$25
$-2.32 (-8.49%)
$23
1 months 13 days ago
(11-Sep-2025)
7/7 (100%)
$1.53 (6.52%)
121
Buy
$35
$7.68 (28.11%)
$27
1 months 14 days ago
(10-Sep-2025)
3/4 (75%)
$10 (40.00%)
157
Buy
$31
$3.68 (13.47%)
$31
2 months 18 days ago
(06-Aug-2025)
6/12 (50%)
$14.09 (83.32%)
223
Buy
$32
$4.68 (17.13%)
$30
2 months 18 days ago
(06-Aug-2025)
11/17 (64.71%)
$15.09 (89.24%)
214
What is TVTX (Travere Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TVTX (Travere Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TVTX (Travere Therapeutics)?
Which analyst is the currently most bullish on TVTX (Travere Therapeutics)?
Which analyst is the currently most reserved on TVTX (Travere Therapeutics)?